| Application no. and date | 16816363.2 (espacenet) (Federated) (European Patent Register), 20161216 | | Patent/reg. no. and date | DK/EP 3390395, 20200909 | | Publication date | 20181024 | | Priority no. and date | GB 201522245, 20151216, GB 201613945, 20160815 | | EP pub. no. and date |
EP 3390395 20181024 | | Effective date | | | Applicant/owner | Loxo Oncology, Inc., Lilly Corporate Centre
Indianapolis
Indiana 46285, US | | Applicant ref. no. | V49708DK00 | | Inventor | GUISOT, Nicolas, c/o Redx Pharma PLC
Block 33F
Mereside
Alderley Park
Alderley Edge
Cheshire SK10 4TG, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/415 (2006.01) , A61K 31/4155 (2006.01) , A61P 35/00 (2006.01) , C07D 231/14 (2006.01) , C07D 401/04 (2006.01) , C07D 401/06 (2006.01) , C07D 403/04 (2006.01) , C07D 405/04 (2006.01) , C07D 405/06 (2006.01) , C07D 405/08 (2006.01) , C07D 405/14 (2006.01) , C07D 413/06 (2006.01) | | Title | Forbindelser, der kan anvendes som kinase-inhibitorer | | Int. application no. | GB2016053968 | | Int. publication no. | WO2017103611 | | Related patent (certificate) | CA 2024 00006 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
